Research Study

W1SDM

Study Status: Not Currently Enrolling 

Study Name: W1SDM  

Study Focus:   Type 1 Diabetes

 

Study Contact: To learn more, please call 407-303-2504 or fill out the Contact us form.

Study Purpose:  To determine if CGM (FDA approved device that provides continuous insight into glucose levels) can reduce hypoglycemia and improve quality of life in older adults with Type 1 diabetes. 

To be enrolled in this study, you must meet certain requirements. You are eligible to participate in one of the following groups if you meet the associated criteria:

  • Diagnosed with Type 1 Diabetes
  • Age ≥ 60
  • Utilize insulin pump or multiple daily insulin injections
  • HbA1c < 10%

Study Duration: 26 weeks

Study Commitment:

  • The study consists of 1 screening visit
  • 9 outpatient visits

Study Procedures:

  • Physical exam, vital signs, height, and weight
  • Assessments
  • Questionnaires

Compensation offered: Yes up to $525.00

This study is being conducted under the direction of Dr. Richard Pratley, at 301 East Princeton Street, Orlando, Florida 32804.